Patents by Inventor Edmund P. Bass

Edmund P. Bass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multivalent felv-infected feline vaccine
    Patent number: 5374424
    Abstract: A multivalent FeLV-infected feline vaccine composed of (1) a small but immunologically effective amount of inactivated feline leukemia virus; (2) a small but effective amount of an inactivated virus selected from the group consisting of Feline Rhinotracheitis Virus, Feline Calici Virus and Feline Panleukopenia Virus; and (3) a pharmaceutically acceptable immunologica adjuvant. Components (1) and (2) may be inactivated by any of the known techniques. The inactivated feline leukemia virus must be from subgroup A and is the Rickard isolate of the virus designated FeLV-A.sub.R1. This combination vaccine is effective in preventing Viremia, leukemia-associated syndromes, and deaths in cats caused by Feline Leukemia Virus, Feline Rhinotracheitis Virus, Feline Calici Virus and Feline Panleukemia Virus infections.
    Type: Grant
    Filed: December 14, 1988
    Date of Patent: December 20, 1994
    Assignee: Miles Inc.
    Inventors: William H. Kelsey, Edmund P. Bass
  • FeLV-infected feline cell line
    Patent number: 5306493
    Abstract: Crandell feline kidney cells infected with a Rickard isolate of FeLV, i.e., FeLV-A.sub.R1, are provided, the infected cells being capable of producing viral materials in amounts sufficient for formulating FeLV vaccines. Processes for producing viral material and FeLV vaccines utilizing the viral material thus prepared also are provided.
    Type: Grant
    Filed: November 15, 1989
    Date of Patent: April 26, 1994
    Assignee: Miles Inc.
    Inventors: William H. Kelsey, Edmund P. Bass
  • Multivalent canine distemper virus vaccine
    Patent number: 5000951
    Abstract: A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
    Type: Grant
    Filed: January 18, 1990
    Date of Patent: March 19, 1991
    Assignee: Diamond Scientific Company
    Inventors: Edmund P. Bass, William H. Kelsey
  • Canine distemper virus vaccine
    Patent number: 4992272
    Abstract: A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
    Type: Grant
    Filed: December 19, 1989
    Date of Patent: February 12, 1991
    Assignee: Diamond Scientific
    Inventors: Edmund P. Bass, William H. Kelsey, Michael D. McFarland
  • Canine distemper virus vaccine
    Patent number: 4990367
    Abstract: A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
    Type: Grant
    Filed: January 12, 1990
    Date of Patent: February 5, 1991
    Assignee: Diamond Scientific Company
    Inventors: Edmund P. Bass, William H. Kelsey, Michael D. McFarland
  • Inactivated rabies vaccine for veterinary use
    Patent number: 4726946
    Abstract: The preparation of a vaccine for immunization of canine and feline animals from inactivated HCP-SAD strain of rabies virus is disclosed.
    Type: Grant
    Filed: April 8, 1985
    Date of Patent: February 23, 1988
    Assignee: Norden Laboratories, Inc.
    Inventors: Edmund P. Bass, Richard L. Sharpee
  • Inactivated rabies vaccine for veterinary use
    Patent number: 4711778
    Abstract: The preparation of a vaccine for immunization of canine and feline animals from inactivated HCP-SAD strain of rabies virus is disclosed.
    Type: Grant
    Filed: May 22, 1985
    Date of Patent: December 8, 1987
    Assignee: Norden Laboratories, Inc.
    Inventors: Edmund P. Bass, Richard L. Sharpee
  • Inactivated rabies vaccine for veterinary use
    Patent number: 4584194
    Abstract: The preparation of a vaccine for immunization of canine and feline animals from inactivated HCP-SAD strain of rabies virus is disclosed.
    Type: Grant
    Filed: April 8, 1985
    Date of Patent: April 22, 1986
    Assignee: Norden Laboratories, Inc.
    Inventors: Edmund P. Bass, Richard L. Sharpee
  • Rabies virus adapted for growth in swine testicle cell culture
    Patent number: 4429045
    Abstract: The preparation of a vaccine for immunization of canine and feline animals from inactivated HCP-SAD strain of rabis virus is disclosed.
    Type: Grant
    Filed: May 10, 1982
    Date of Patent: January 31, 1984
    Assignee: Norden Laboratories, Inc.
    Inventors: Edmund P. Bass, Richard L. Sharpee
  • Inactivated rabies vaccine for veterinary use
    Patent number: 4347239
    Abstract: The preparation of a vaccine for immunization of canine and feline animals from inactivated HCP-SAD strain of rabies virus is disclosed.
    Type: Grant
    Filed: July 30, 1980
    Date of Patent: August 31, 1982
    Assignee: Norden Laboratories, Inc.
    Inventors: Edmund P. Bass, Richard L. Sharpee